NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 66 filers reported holding NOVELION THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,034,000 | -19.6% | 1,025,000 | 0.0% | 0.67% | -11.5% |
| Q2 2018 | $3,772,000 | +5.2% | 1,025,000 | 0.0% | 0.76% | -8.9% |
| Q1 2018 | $3,587,000 | +12.2% | 1,025,000 | 0.0% | 0.83% | +1.3% |
| Q4 2017 | $3,198,000 | -55.6% | 1,025,000 | 0.0% | 0.82% | -63.2% |
| Q3 2017 | $7,205,000 | -23.8% | 1,025,000 | 0.0% | 2.22% | -29.6% |
| Q2 2017 | $9,460,000 | -14.1% | 1,025,000 | 0.0% | 3.16% | -27.4% |
| Q1 2017 | $11,008,000 | +27.6% | 1,025,000 | 0.0% | 4.35% | +83.0% |
| Q4 2016 | $8,630,000 | – | 1,025,000 | – | 2.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|